All News

A breast cancer and melanoma survivor encourages looking forward to the New Year.

Each new year, many make resolutions for change. For the person with cancer, resolutions are important but also need to be realistic.

The Food and Drug Administration approved the first PARP inhibitor for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated metastatic pancreatic adenocarcinoma.

One survivor reflects on life after cancer on "cannoli Monday."

As 2019 comes to a close, take a read through CURE®’s top stories of the year.

One male breast cancer survivor reflects on revolutionary developments from the San Antonio Breast Cancer Symposium.

Sometimes the imperfections in life can bring an unexpected beauty. A famous mystery author explores this idea.

The Food and Drug Administration’s accelerated approval of Padcev offers patients with advanced bladder cancer a potential standard of care.

An improved app sends clinical trials straight to the phone of this patient with breast cancer (and she can forward them right to her doctor).

Take a look back at the top 10 podcasts of 2019 – and be sure to subscribe so you don’t miss an episode in 2020.

If you’ve experienced neuropathy, you know what it entails.

A diagnosis of breast cancer can cause a person to become very fearful especially when the future holds so many unknowns, but it’s not healthy to live under an umbrella of fear. In this article, survivor, Bonnie Annis, shares her experience.

The author uses a well-known story about landing in another country to explain cancer journeys.

A two-time cancer survivor suggests simplifying the holidays when coping with cancer.